Stock FULC FULCRUM THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Fulcrum Therapeutics, Inc.

Equities

FULC

US3596161097

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
8.01 USD +2.69% Intraday chart for Fulcrum Therapeutics, Inc. +29.40% +18.67%
Jul. 01 Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) added to Russell Small Cap Comp Value Index CI
Jul. 01 Fulcrum Therapeutics, Inc.(NasdaqGM:FULC) added to Russell Small Cap Completeness Index CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fulcrum Therapeutics, Inc. Elects Colin Hill as A Member of the Board
CI
Fulcrum Therapeutics Appoints Patrick Horn as Chief Medical Officer
MT
Fulcrum Therapeutics, Inc. Announces Executive Changes
CI
GSK: Dr Jeannie Lee joins the Board of Directors
CF
Spero Therapeutics Appoints Esther Rajavelu Chief Financial Officer
MT
Fulcrum Therapeutics, Inc. Announces Resignation of Mel Hayes as Chief Operating Officer
CI
Fulcrum Therapeutics Names Alan Musso Chief Financial Officer
MT
Fulcrum Therapeutics, Inc. Announces Management Changes
CI
Fulcrum Therapeutics, Inc. Chief Executive Officer Changes
CI
Fulcrum Therapeutics Appoints Alex C. Sapir as President, Chief Executive
MT
Fulcrum Therapeutics Finance Chief Esther Rajavelu Resigns
MT
Fulcrum Therapeutics, Inc. Announces Resignation of Esther Rajavelu as Treasurer, Effective April 21, 2023
CI
Fulcrum Therapeutics, Inc. Announces Resignation of Esther Rajavelu as Chief Financial Officer, Effective April 21, 2023
CI
Fulcrum Therapeutics Chief Medical Officer Santiago Arroyo Resigns; Shares Drop
MT
Fulcrum Therapeutics, Inc. Announces Executive Changes
CI
Fulcrum Therapeutics CEO Bryan Stuart Steps Down, Robert Gould Named Interim CEO
MT
Fulcrum Therapeutics, Inc. Announces Resignation of Bryan Stuart from the Board of Directors
CI
Fulcrum Therapeutics, Inc. Announces CEO Transition
CI
Fulcrum Therapeutics Appoints Santiago Arroyo as Chief Medical Officer, Jeff Jacobs as Chief Scientific Officer
MT
Fulcrum Therapeutics, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FULC Stock
  4. News Fulcrum Therapeutics, Inc.
  5. Insiders